Definium Therapeutics (DFTX) Share-based Compensation (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Definium Therapeutics | 2.42 Bn | 2.06 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.33% |
| Dec 31, 2025 | -3.70% |
| Sep 30, 2025 | 10.72% |
| Jun 30, 2025 | 53.33% |
| Mar 31, 2025 | -13.33% |
| Dec 31, 2024 | 2.92% |
| Sep 30, 2024 | -29.26% |
| Jun 30, 2024 | 47.19% |
| Mar 31, 2024 | 9.63% |
| Dec 31, 2023 | -20.37% |
| Sep 30, 2023 | 9.99% |
| Jun 30, 2023 | 2.45% |
| Mar 31, 2023 | 172.53% |
| Dec 31, 2022 | -67.90% |
| Sep 30, 2022 | 0.78% |
| Jun 30, 2022 | 12.16% |
| Mar 31, 2022 | -12.69% |
| Dec 31, 2021 | 5.80% |
| Sep 30, 2021 | -87.56% |
| Jun 30, 2021 | 2,479.20% |
| Mar 31, 2021 | -86.65% |
| Jun 30, 2020 | -101.40% |
| Mar 31, 2020 | 2,834.25% |